| pubmed-article:15463886 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15463886 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15463886 | lifeskim:mentions | umls-concept:C0010674 | lld:lifeskim |
| pubmed-article:15463886 | lifeskim:mentions | umls-concept:C0887942 | lld:lifeskim |
| pubmed-article:15463886 | lifeskim:mentions | umls-concept:C0006279 | lld:lifeskim |
| pubmed-article:15463886 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15463886 | pubmed:dateCreated | 2004-10-6 | lld:pubmed |
| pubmed-article:15463886 | pubmed:abstractText | The antimicrobial peptides human beta-defensin 1 and 2 (hBD-1 and 2) and the cathelicidin LL-37/hCAP-18 are key factors in innate immune responses of the respiratory tract. The aim of this study was to determine the concentrations of these peptides in airway surface fluid of CF patients with mild lung disease. | lld:pubmed |
| pubmed-article:15463886 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15463886 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15463886 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15463886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15463886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15463886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15463886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15463886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15463886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15463886 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15463886 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:15463886 | pubmed:issn | 1569-1993 | lld:pubmed |
| pubmed-article:15463886 | pubmed:author | pubmed-author:WahnUlrichU | lld:pubmed |
| pubmed-article:15463886 | pubmed:author | pubmed-author:Schaller-Bals... | lld:pubmed |
| pubmed-article:15463886 | pubmed:author | pubmed-author:BalsRobertR | lld:pubmed |
| pubmed-article:15463886 | pubmed:author | pubmed-author:ChenChristian... | lld:pubmed |
| pubmed-article:15463886 | pubmed:author | pubmed-author:PaulKarl PKP | lld:pubmed |
| pubmed-article:15463886 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15463886 | pubmed:volume | 3 | lld:pubmed |
| pubmed-article:15463886 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15463886 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15463886 | pubmed:pagination | 45-50 | lld:pubmed |
| pubmed-article:15463886 | pubmed:dateRevised | 2010-9-17 | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:meshHeading | pubmed-meshheading:15463886... | lld:pubmed |
| pubmed-article:15463886 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15463886 | pubmed:articleTitle | Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. | lld:pubmed |
| pubmed-article:15463886 | pubmed:affiliation | Department of Pediatric Pneumology and Immunology, Charité, Humboldt-University, Berlin, Germany. | lld:pubmed |
| pubmed-article:15463886 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15463886 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15463886 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:83687 | entrezgene:pubmed | pubmed-article:15463886 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15463886 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15463886 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15463886 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15463886 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15463886 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15463886 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15463886 | lld:pubmed |
